“…The H9 line of ESCs used in this study were purchased from the WiCell Institute (Madison, WI). Differentiation of cells was performed as described previously (Hewitt et al, 2009). Briefly, iPSCs (iPS-1, passage 12, iPS-2, passage 30) or ESCs were plated as aggregates onto fixed MEFs, and cultured in medium consisting of 3:1 DMEM:F12 (Invitrogen, Carlsbad, CA), 5% FCII (Hyclone, Logan, UT), 0.18 mM adenine, 0.5 mg/ml hydrocortisone, 10 210 M cholera toxin, 10 ng/ml EGF, 5 mg/ml insulin for 7 days and supplemented on days 4-7 with 0.5 nM BMP-4.…”